Drugs / boronophenylalanine-fructose complex
boronophenylalanine-fructose complex
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00062348 | Apr 2003 → Dec 2007 | colorectal cancer, head and neck cancer, metastatic malignant neoplasm | European Organisation for Research and Treatment of Cancer - EORTC | Completed | No outcome recorded |
| Phase 1 | NCT00002781 | Apr 1996 → ? | cutaneous melanoma | Beth Israel Deaconess Medical Center | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00039572 | May 2002 → Jan 2005 | central nervous system neoplasm, cutaneous melanoma, metastatic malignant neoplasm | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00085059 | Apr 2004 → Oct 2006 | cutaneous melanoma | European Organisation for Research and Treatment of Cancer - EORTC | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | borono-phenylalanine-fructose complex | “Metabolism of borono-phenylalanine-fructose complex (BPA-fr) and borocaptate sodium (BSH) in cancer patients--results from EORTC trial 11001.” PMID 19735988 ↗ Aug 2009 |
| Known as | borophenylalanine-fructose complex | “Patients receive a test dose of borophenylalanine-fructose complex (BPA-F) for biodistribution studies” NCT00002781 ↗ |
| Known as | BPA-F | “Patients receive a test dose of borophenylalanine-fructose complex (BPA-F) for biodistribution studies” NCT00002781 ↗1“Patients receive boronophenylalanine-fructose complex (BPA-F) IV over 1 hour.” NCT00062348 ↗ |
| Known as | BPA-fr | “Metabolism of borono-phenylalanine-fructose complex (BPA-fr) and borocaptate sodium (BSH) in cancer patients--results from EORTC trial 11001.” PMID 19735988 ↗ Aug 2009 |
| Route | Intravenous | “boronophenylalanine-fructose complex IV over 90 minutes” NCT00039572 ↗ |